Systematic Review: Safety of Intravesical Therapy for Bladder Cancer in the Era of COVID-19

A novel coronavirus has emerged in late 2019 capable of causing a severe respiratory disease known as COVID-19. Its pathogenesis appears to be the initiation of an immune response and resulting cytokine storm that damages the healthy lung tissue of the host. Some epidemiological studies found bacill...

Descripción completa

Detalles Bibliográficos
Autores principales: Leeson, Cale E., Ismail, Asmaa, Hashad, Mohamed M., Elmansy, Hazem, Shahrour, Walid, Prowse, Owen, Kotb, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433676/
https://www.ncbi.nlm.nih.gov/pubmed/32838196
http://dx.doi.org/10.1007/s42399-020-00461-3
Descripción
Sumario:A novel coronavirus has emerged in late 2019 capable of causing a severe respiratory disease known as COVID-19. Its pathogenesis appears to be the initiation of an immune response and resulting cytokine storm that damages the healthy lung tissue of the host. Some epidemiological studies found bacillus Calmette-Guérin (BCG) vaccine can help to decrease morbidity and mortality of the viral infection. We aim to review and summarize what is known about COVID-19 and the current implications of intravesical BCG with regard to the disease.

Ejemplares similares